KRISTALLFORMEN

Patent europeic · EP4403223 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4403223
Numer da la dumonda
EP24151934
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
05-06-2015
Publitgà
24-07-2024
Concedì
13-05-2026
La protecziun finescha il pli tard
04-06-2035
Proxima taxa annuala scadenta
30-06-2027
Classas IPC
C07K 5/083 (2006.01)
A61P 31/14 (2006.01)
A61K 38/12 (2006.01)
Prioritad
US 201462008786 P 06.06.2014
Derivà da
EP15803592
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 03-08-2026

    Adressa dal possessur midada

    Owner
    AbbVie Inc., 1 North Waukegan Road, V0377, Chicago, IL 60064, USA → AbbVie Inc., 1 N. Waukegan Road, North Chicago, IL 60064, USA

    Published in Swissreg on 03.08.2026

  2. 01-07-2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  3. 19-05-2026

    Represchentant inscrit

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 19.05.2026

  4. 13-05-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 13.05.2026

Partidas

Possessur

Abbvie Inc.

AbbVie Inc.

1 N. Waukegan Road, North Chicago, IL 60064, US

Represchentant

Novagraaf International SA

Chemin de l'Echo 3, 1213 Onex

Inventur

CHEN, Shuang

Gurnee, 60031, US

GATES, Bradley D.

Mt. Prospect, 60056, US

SHEIKH, Ahmad Y.

Deerfield, 60015, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.